Top

Published in:

Open Access 01-08-2021 | Human Immunodeficiency Virus | Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters

Authors: Wendee M. Wechsberg, Felicia A. Browne, Courtney Peasant Bonner, Yukiko Washio, Brittni N. Howard, Isa van der Drift

Published in: Current HIV/AIDS Reports | Issue 4/2021

Abstract

Purpose of Review

Alcohol is the most misused substance in the world. For people living with HIV (PLWH), alcohol misuse may impact ART adherence and viral suppression. This review of the most recently published alcohol intervention studies with PLWH examines how these studies considered gender in the samples, design, and analyses.

Recent Findings

Three searches were conducted initially, and 13 intervention studies fit our criteria with alcohol outcomes. In general, most studies did not consider gender and had used small samples, and few demonstrated significant efficacy/effectiveness outcomes. Five studies considered gender in their samples or analyses and/or were woman-focused with larger samples and demonstrated significant outcomes.

Summary

It is essential for women who misuse alcohol to not only be well represented in alcohol and HIV research but also for studies to consider the barriers to reaching them and their contextual demands and/or co-occurring issues that may affect participation and outcomes in intervention research.

Available only for authorised users

The World Bank. Global Economic Prospects. Washington, D.C. 2021.

Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132–e41. https://doi.org/10.25561/78670.

Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308–e9. https://doi.org/10.1016/S2352-3018(20)30105-3.

The Lancet. Maintaining the HIV response in a world shaped by COVID-19: Editorial. Elsevier; 2020396(10264). https://doi.org/10.1016/S0140-6736(20)32526-5.

Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26. https://doi.org/10.1111/add.14234.CrossRefPubMed

Kelso-Chichetto NE, Plankey M, Abraham AG, Ennis N, Chen X, Bolan R, et al. Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV. Am J Drug Alcohol Abuse. 2018;44(1):85–94. https://doi.org/10.1080/00952990.2017.1335317.CrossRefPubMed

Lipira L, Rao D, Nevin PE, Kemp CG, Cohn SE, Turan JM, et al. Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV. Drug Alcohol Depend. 2020;206:107753. https://doi.org/10.1016/j.drugalcdep.2019.107753.CrossRefPubMed

Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93. https://doi.org/10.1016/j.drugalcdep.2010.06.014.

Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review. Curr HIV/AIDS Rep. 2015;12(4):421–36. https://doi.org/10.1007/s11904-015-0285-5.

10.

U.S. Department of Veterans Affairs. Primary care of veterans with HIV. 2019.

11.

Rooks-Peck CR, Adegbite AH, Wichser ME, Ramshaw R, Mullins MM, Higa D, et al. Mental health and retention in HIV care: a systematic review and meta-analysis. Health Psychol. 2018;37(6):574–85. https://doi.org/10.1037/hea0000606.CrossRefPubMedPubMedCentral

12.

Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134–40. https://doi.org/10.1080/09540120701351888.CrossRefPubMedPubMedCentral

13.

Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459–66. https://doi.org/10.1080/09540120601095734.CrossRefPubMedPubMedCentral

14.

Bryant KJ, Nelson S, Braithwaite RS, Roach D. Integrating HIV/AIDS and alcohol research. Alcohol Res Health. 2010;33(3):167–78.PubMedPubMedCentral

15.

Scott-Sheldon LA, Carey KB, Johnson BT, Carey MP. Behavioral interventions targeting alcohol use among people living with HIV/AIDS: a systematic review and meta-analysis. AIDS Behav. 2017;21(2):126–43. https://doi.org/10.1007/s10461-017-1886-3.

16.

Brown JL, DeMartini KS, Sales JM, Swartzendruber AL, DiClemente RJ. Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature. Curr HIV/AIDS Rep. 2013;10(4):356–70. https://doi.org/10.1007/s11904-013-0174-8.

17.

Madhombiro M, Musekiwa A, January J, Chingono A, Abas M, Seedat S. Psychological interventions for alcohol use disorders in people living with HIV/AIDS: a systematic review. Syst Rev. 2019;8(1):1–16. https://doi.org/10.1186/s13643-019-1176-4.

18.

Goh ET, Morgan MY. Pharmacotherapy for alcohol dependence–the why, the what and the wherefore. Aliment Pharmacol Ther. 2017;45(7):865–82.

19.

Farhadian N, Moradi S, Zamanian MH, Farnia V, Rezaeian S, Farhadian M, et al. Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review. Subst Abuse Treat Prev Policy. 2020;15(1):1–7. https://doi.org/10.1186/s13011-020-00266-6

20.

Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17. https://doi.org/10.1001/jama.295.17.2003.

21.

Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, et al. Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. Lancet HIV. 2019;6(8):e509–e17. https://doi.org/10.1016/S2352-3018(19)30076-1.

22.

Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: a randomized controlled trial. J Consult Clin Psychol. 2018;86(8):645–56. https://doi.org/10.1037/ccp0000322.

23.

Wray TB, Kahler CW, Simpanen EM, Operario D. A preliminary randomized controlled trial of game plan, a web application to help men who have sex with men reduce their HIV risk and alcohol use. AIDS Behav. 2019;23(6):1668–79. https://doi.org/10.1007/s10461-019-02396-w.

24.

Sikkema KJ, Hansen NB, Kochman A, Santos J, Watt MH, Wilson PA, et al. The development and feasibility of a brief risk reduction intervention for newly HIV-diagnosed men who have sex with men. J Community Psychol. 2011;39(6):717–32. https://doi.org/10.1002/jcop.20463.

25.

Zule W, Myers B, Carney T, Novak SP, McCormick K, Wechsberg WM. Alcohol and drug use outcomes among vulnerable women living with HIV: results from the Western Cape Women’s Health CoOp. AIDS Care. 2014;26(12):1494–9. https://doi.org/10.1080/09540121.2014.933769.

26.

Cook RL, Zhou Z, Miguez MJ, Quiros C, Espinoza L, Lewis JE, et al. Reduction in drinking was associated with improved clinical outcomes in women with HIV infection and unhealthy alcohol use: results from a randomized clinical trial of oral naltrexone versus placebo. Alcohol Clin Exp Res. 2019;43(8):1790–800. https://doi.org/10.1111/acer.14130.

27.

Wechsberg WM, Bonner CP, Zule WA, van der Horst C, Ndirangu J, Browne FA, et al. Addressing the nexus of risk: Biobehavioral outcomes from a cluster randomized trial of the Women’s Health CoOp Plus in Pretoria, South Africa. Drug Alcohol Depend. 2019;195:16–26. https://doi.org/10.1016/j.drugalcdep.2018.10.036.CrossRefPubMed

28.

Food Drug Administration: Center for Drug Evaluation and Research. General considerations for the clinical evaluation of drugs. Rockville, MD. 1977.

29.

Institute of Medicine (US) Committee on Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies; Mastroianni AC FR, Federman D, editors,. Women and health research: ethical and legal issues of including women in clinical studies: Volume I. Washington (DC): National Academies Press (US); NIH Revitalization Act of 1993 Public Law 103-43. 1994.

30.

Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74(9):911–23. https://doi.org/10.1001/jamapsychiatry.2017.2161.CrossRefPubMedPubMedCentral

31.

Hasin DS, Shmulewitz D, Keyes K. Alcohol use and binge drinking among U.S. men, pregnant and non-pregnant women ages 18–44: 2002–2017. Drug Alcohol Depend. 2019;205:107590. https://doi.org/10.1016/j.drugalcdep.2019.107590.CrossRefPubMedPubMedCentral

32.

Bye EK, Moan IS. Trends in older adults’ alcohol use in Norway 1985–2019. Nordic Stud Alcohol Drugs. 2020;37(5):444–58. https://doi.org/10.1177/1455072520954325.

33.

Slade T, Chapman C, Swift W, Keyes K, Tonks Z, Teesson M. Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression. BMJ Open. 2016;6(10). https://doi.org/10.1136/bmjopen-2016-011827.

34.

Erol A, Karpyak VM. Sex and gender-related differences in alcohol use and its consequences: contemporary knowledge and future research considerations. Drug Alcohol Depend. 2015;156:1–13. https://doi.org/10.1016/j.drugalcdep.2015.08.023.CrossRefPubMed

35.

Garbutt JC, Kranzler HR, O’Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617–25. https://doi.org/10.1001/jama.293.13.1617.

36.

National Institute on Alcohol Abuse and Alcoholism: Fact sheet: women and alcohol. 2020. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/women-and-alcohol. Accessed 02.08.2021.

37.

May PA, Marais A-S, Gossage JP, Barnard R, Joubert B, Cloete M, et al. Case management reduces drinking during pregnancy among high risk women. Int J Alcohol Drug Res. 2013;2(3):61–70. https://doi.org/10.3390/ijerph13010076.

38.

De Vries MM, Joubert B, Cloete M, Roux S, Baca BA, Hasken JM, et al. Indicated prevention of fetal alcohol spectrum disorders in South Africa: effectiveness of case management. Int J Environ Res Public Health. 2016;13(1):76. https://doi.org/10.7895/ijadr.v2i3.79.

39.

Omonaiye O, Kusljic S, Nicholson P, Manias E. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review. BMC Public Health. 2018;18(1):1–20. https://doi.org/10.1186/s12889-018-5651-y.

40.

Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(10):948–56. https://doi.org/10.1001/jamapediatrics.2017.1919.

41.

Russell BS, Eaton LA, Petersen-Williams P. Intersecting epidemics among pregnant women: alcohol use, interpersonal violence, and HIV infection in South Africa. Curr HIV/AIDS Rep. 2013;10(1):103–10. https://doi.org/10.1007/s11904-012-0145-5.

42.

Adeniyi OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(1):175. https://doi.org/10.1186/s12879-018-3087-8.

43.

Skagerstrom J, Chang G, Nilsen P. Predictors of drinking during pregnancy: a systematic review. J Women's Health. 2011;20(6):901–13. https://doi.org/10.1089/jwh.2010.2216.

44.

Washio Y, Frederick J, Archibald A, Bertram N, Crowe JA. Community-initiated pilot program “My Baby’s Breath” to reduce prenatal alcohol use. Del Med J. 2017;89(2):46–51.PubMed

45.

Jones HE, Berkman ND, Kline TL, Ellerson RM, Browne FA, Poulton W, et al. Initial feasibility of a woman-focused intervention for pregnant African-American women. Int J Pediatr. 2011;2011:389285–7. https://doi.org/10.1155/2011/389285.CrossRefPubMedPubMedCentral

46.

Jones HE, Myers B, O’Grady KE, Gebhardt S, Theron GB, Wechsberg WM. Initial feasibility and acceptability of a comprehensive intervention for methamphetamine-using pregnant women in South Africa. Psychiatry J. 2014;2014:1–8. https://doi.org/10.1155/2014/929767.CrossRef

47.

National Institute on Alcohol Abuse and Alcoholism: Rethinking drinking: alcohol & your health: what are the different drinking levels? 2015. https://www.rethinkingdrinking.niaaa.nih.gov/how-much-is-too-much/is-your-drinking-pattern-risky/Drinking-Levels.aspx. Accessed 02.08.2021.

48.

Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med. 1978;298(19):1063–7. https://doi.org/10.1056/nejm197805112981906.CrossRefPubMed

49.

Hayden MR, Nelson MM. The fetal alcohol syndrome. S Afr Med J. 1978;54(14):571–4.PubMed

50.

Mirtsou-Fidani V, Makedou K, Kourti M, Karakiulakis G. The fetal alcohol syndrome. S Afr Med J. 1997;15:84–90.

51.

May PA, Hymbaugh KJ, Aase JM, Samet JM. Epidemiology of fetal alcohol syndrome among American Indians of the Southwest. Soc Biol. 1983;30(4):374–87. https://doi.org/10.1080/19485565.1983.9988551.CrossRefPubMed

52.

Aase JM. The fetal alcohol syndrome in American Indians: a high risk group. Neurobehav Toxicol Teratol. 1981;3(2):153–6.PubMed

53.

Hutton HE, Lesko CR, Li X, Thompson CB, Lau B, Napravnik S, et al. Alcohol use patterns and subsequent sexual behaviors among women, men who have sex with men and men who have sex with women engaged in routine HIV care in the United States. AIDS Behav. 2019;23(6):1634–46. https://doi.org/10.1007/s10461-018-2337-5.CrossRefPubMedPubMedCentral

54.

Neblett RC, Hutton HE, Lau B, McCaul ME, Moore RD, Chander G. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. J Women's Health. 2011;20(2):279–86. https://doi.org/10.1089/jwh.2010.2043.CrossRef

55.

Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women's Health. 2011;20(7):991–1006. https://doi.org/10.1089/jwh.2010.2328.CrossRef

56.

Theall KP, Amedee A, Clark RA, Dumestre J, Kissinger P. Alcohol consumption and HIV-1 vaginal RNA shedding among women. J Stud Alcohol Drugs. 2008;69(3):454–8. https://doi.org/10.15288/jsad.2008.69.454.

57.

Carter M. AIDSMap: Genital shedding of HIV fluctuates with a woman’s menstrual cycle. 2004. https://www.aidsmap.com/news/jun-2004/genital-shedding-hiv-fluctuates-womans-menstrual-cycle. Accessed 2/08/2021.

58.

Carter M. AIDSMap: variations in genital shedding of HIV during menstrual cycle large enough to impact on risk of sexual transmission. 2013. https://www.aidsmap.com/news/feb-2013/variations-genital-shedding-hiv-during-menstrual-cycle-large-enough-impact-risk. Accessed 2.08.2021.

59.

Centers for Disease Control and Prevention. PRS efficacy criteria for good-evidence risk reduction (RR) individual-level, group-level, and couple-level interventions (ILIs/GLIs/CPLs). 2014. https://www.cdc.gov/hiv/pdf/dhap/prb/prs/efficacy/rr/criteria/HIV-RR-Efficacy-Best-ILI-GLI-CPLs.pdf.

60.

Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97(1):133–43. https://doi.org/10.2105/ajph.2005.076182.CrossRefPubMedPubMedCentral

61.

Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, et al. Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial. Addict Sci Clin Pract. 2020;15(1):1–12. https://doi.org/10.1186/s13722-020-00200-y.

62.

Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, et al. Integrated stepped alcohol treatment for patients with HIV and liver disease: a randomized trial. J Subst Abus Treat. 2019;106:97–106. https://doi.org/10.1016/j.jsat.2019.08.007.

63.

Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NV, et al. Effect of 2 integrated interventions on alcohol abstinence and viral suppression among Vietnamese adults with hazardous alcohol use and HIV: A randomized clinical trial. JAMA Netw Open. 2020;3(9):e2017115. https://doi.org/10.1001/jamanetworkopen.2020.17115.

64.

Naar S, Robles G, MacDonell KK, Dinaj-Koci V, Simpson KN, Lam P, et al. Comparative effectiveness of community-based vs clinic-based Healthy Choices Motivational Intervention to improve health behaviors among youth living with HIV: a randomized clinical trial. JAMA Netw Open. 2020;3(8):e2014650. https://doi.org/10.1001/jamanetworkopen.2020.17115.

65.

Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, et al. Interventions to reduce unhealthy alcohol use among primary care patients with HIV: the health and motivation randomized clinical trial. J Gen Intern Med. 2019;34(10):2054–61. https://doi.org/10.1007/s11606-019-05065-9.

66.

Stein MD, Herman DS, Kim HN, Howell A, Lambert A, Madden S, et al. A randomized trial comparing brief advice and motivational interviewing for persons with HIV–HCV co-infection who drink alcohol. AIDS Behav. 2020:1–13. https://doi.org/10.1007/s10461-020-03062-2.

67.

Madhombiro M, Kidd M, Dube B, Dube M, Mutsvuke W, Muronzie T, et al. Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial. J Int AIDS Soc. 2020;23(12):e25641. https://doi.org/10.1002/jia2.25641.

68.

Huis in’t Veld D, Ensoy-Musoro C, Pengpid S, Peltzer K, Colebunders R. The efficacy of a brief intervention to reduce alcohol use in persons with HIV in South Africa, a randomized clinical trial. PLoS One. 2019;14(8):e0220799. https://doi.org/10.1371/journal.pone.0220799.

69.

Wechsberg WM, Browne FA, Ndirangu J, Bonner CP, Kline TL, Gichane M, et al. Outcomes of Implementing in the real world the Women's Health CoOp intervention in Cape Town, South Africa. AIDS Behav. 2021. https://doi.org/10.1007/s10461-021-03251-7.

70.

Papas RK, Gakinya BN, Mwaniki MM, Lee H, Keter AK, Martino S, et al. A randomized clinical trial of a group cognitive-behavioral therapy to reduce alcohol use among human immunodeficiency virus-infected outpatients in western Kenya. Addiction. 2021;116(2):305–18. https://doi.org/10.1111/add.15112.CrossRefPubMed

71.

DiClemente RJ, Brown JL, Capasso A, Revzina N, Sales JM, Boeva E, et al. Computer-based alcohol reduction intervention for alcohol-using HIV/HCV co-infected Russian women in clinical care: Study protocol for a randomized controlled trial. Trials. 2021;22(1):1–12. https://doi.org/10.21203/rs.3.rs-45325/v1.CrossRef

72.

Kane JC, Sharma A, Murray LK, Chander G, Kanguya T, Lasater ME, et al. Common Elements Treatment Approach (CETA) for unhealthy alcohol use among persons with HIV in Zambia: study protocol of the ZCAP randomized controlled trial. Addict Behav Rep. 2020;12:100278. https://doi.org/10.1016/j.abrep.2020.100278.

73.

Magidson JF, Joska JA, Myers B, Belus JM, Regenauer KS, Andersen LS, et al. Project Khanya: a randomized, hybrid effectiveness-implementation trial of a peer-delivered behavioral intervention for ART adherence and substance use in Cape Town, South Africa. Implement Sci Commun. 2020;1(1):1–12. https://doi.org/10.1186/s43058-020-00004-w.

74.

Wechsberg WM, Myers B, Reed E, Carney T, Emanuel AN, Browne FA. Substance use, gender inequity, violence and sexual risk among couples in Cape Town. Cult Health Sex. 2013;15(10):1221–36. https://doi.org/10.1080/13691058.2013.815366.CrossRefPubMed

75.

Howard BN, Van Dorn R, Myers BJ, Zule WA, Browne FA, Carney T, et al. Barriers and facilitators to implementing an evidence-based woman-focused intervention in South African health services. BMC Health Serv Res. 2017;17(1):746. https://doi.org/10.1186/s12913-017-2669-2.CrossRefPubMedPubMedCentral

76.

Myers B, Carney T, Wechsberg WM. “Not on the agenda”: a qualitative study of influences on health services use among poor young women who use drugs in Cape Town, South Africa. Int J Drug Policy. 2016;30:52–8. https://doi.org/10.1016/j.drugpo.2015.12.019.CrossRefPubMed

77.

Meyer JP, Isaacs K, El-Shahawy O, Burlew AK, Wechsberg W. Research on women with substance use disorders: reviewing progress and developing a research and implementation roadmap. Drug Alcohol Depend. 2019;197:158–63. https://doi.org/10.1016/j.drugalcdep.2019.01.017.CrossRefPubMedPubMedCentral

78.

Myers B, Louw J, Pasche S. Gender differences in barriers to alcohol and other drug treatment in Cape Town, South Africa. Afr J Psychiatry. 2011;14(2):146–53. https://doi.org/10.4314/ajpsy.v14i2.7.CrossRef

79.

Hu X, Harman J, Winterstein AG, Zhong Y, Wheeler AL, Taylor TN, et al. Utilization of alcohol treatment among HIV-positive women with hazardous drinking. J Subst Abus Treat. 2016;64:55–61. https://doi.org/10.1016/j.jsat.2016.01.011.

80.

Myers B, Fakier N, Louw J. Stigma, treatment beliefs, and substance abuse treatment use in historically disadvantaged communities. Afr J Psychiatry. https://doi.org/10.4314/ajpsy.v12i3.48497.

81.

McCrady BS, Epstein EE, Fokas KF. Treatment interventions for women with alcohol use disorder. Alcohol Res Health. 2020;40(2). https://doi.org/10.35946/arcr.v40.2.08.

82.

Wechsberg WM, Browne FA, Poulton W, Ellerson RM, Simons-Rudolph A, Haller D. Adapting an evidence-based HIV prevention intervention for pregnant African-American women in substance abuse treatment. Subst Abus Rehabil. 2011;2(1):35–42. https://doi.org/10.2147/SAR.S16370.CrossRef

83.

Wechsberg WM. Adapting HIV interventions for women substance abusers in international settings: lessons for the future. J Drug Issues. 2009;39(1):237–43.CrossRef

84.

Wechsberg WM, Browne FA, Ellerson RM, Zule WA. Adapting the evidence-based Women’s CoOp intervention to prevent human immunodeficiency virus infection in North Carolina and international settings. N C Med J. 2010;71(5):477–81.PubMedPubMedCentral

85.

Hughes TL, Eliason M. Substance use and abuse in lesbian, gay, bisexual and transgender populations. J Prim Prev. 2002;22(3):263–98. https://doi.org/10.1037/a0025424.

86.

Hughes TL, Veldhuis CB, Drabble LA, Wilsnack SC. Research on alcohol and other drug (AOD) use among sexual minority women: a global scoping review. PLoS One. 2020;15(3):e0229869. https://doi.org/10.1371/journal.pone.0229869.

87.

Hughes, TL, Wilsnack SC, Kantor LW. The influence of gender and sexual orientation on alcohol use and alcohol-related problems: toward a global perspective. Alcohol Res Health. 2016;38(1):121-32.

88.

Popova S, Lange S, Probst C, Gmel G, Rehm J. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem Cell Biol. 2018;96(2):237–40. https://doi.org/10.1139/bcb-2017-0077.CrossRefPubMed

89.

Olivier L, Curfs L, Viljoen D. Fetal alcohol spectrum disorders: prevalence rates in South Africa. S Afr Med J. 2016;106(6):S103. https://doi.org/10.7196/SAMJ.2016.v106i6.11009.

90.

Wynn A, Rotheram-Borus MJ, Davis E, le Roux I, Almirol E, O’Connor M, et al. Identifying fetal alcohol spectrum disorder among South African children at aged 1 and 5 years. Drug Alcohol Depend. 2020;217:108266. https://doi.org/10.1016/j.drugalcdep.2020.108266.

91.

Gichane MW, Wechsberg WM, Ndirangu J, Browne FA, Bonner CP, Grimwood A, et al. Implementation science outcomes of a gender-focused HIV and alcohol risk-reduction intervention in usual-care settings in South Africa. Drug Alcohol Depend. 2020;215:108206. https://doi.org/10.1016/j.drugalcdep.2020.108206.

Title: Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters
Authors: Wendee M. Wechsberg
Felicia A. Browne
Courtney Peasant Bonner
Yukiko Washio
Brittni N. Howard
Isa van der Drift
Publication date: 01-08-2021
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: Current HIV/AIDS Reports / Issue 4/2021
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-021-00558-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2021

Novel Longitudinal Methods for Assessing Retention in Care: a Synthetic Review

Application of the Consolidated Framework for Implementation Research to Facilitate Violence Screening in HIV Care Settings: a Review of the Literature

Technology-Delivered Intervention Strategies to Bolster HIV Testing

The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs

Strategies for Successful Clinical Trial Recruitment of People Living with HIV in Low- and Middle-Income Countries: Lessons Learned and Implementation Implications from the Nigeria Renal Risk Reduction (R3) Trial

Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page